Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

(2016) Angelica Loskog et al.   BRITISH JOURNAL OF CANCER

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

(2016) Alain P. Algazi et al.   CANCER

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

(2016) C. Alfaro et al.   CLINICAL CANCER RESEARCH

CD6 modulates thymocyte selection and peripheral T cell homeostasis

(2016) Marc Orta-Mascaró et al.   JOURNAL OF EXPERIMENTAL MEDICINE

CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes

(2014) L Liljenfeldt et al.   CANCER GENE THERAPY

C-KIT Signaling in Cancer Treatment

(2014) Karmen Stankov et al.   CURRENT PHARMACEUTICAL DESIGN

The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis

(2014) Gustav J. Ullenhag et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival

(2014) Y. Kikushige et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Flt3 Ligand Mediates STAT3-Independent Expansion but STAT3-Dependent Activation of Myeloid-Derived Suppressor Cells

(2014) B. R. Rosborough et al.   JOURNAL OF IMMUNOLOGY

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

(2013) Christiane Meyer et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Opportunities for Sensitive Plasma Proteome Analysis

(2012) Ulf Landegren et al.   ANALYTICAL CHEMISTRY

Melanoma as a model tumour for immuno-oncology

(2012) M. Maio   ANNALS OF ONCOLOGY

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells

(2012) Hsin-Yi Tseng et al.   CARCINOGENESIS

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

(2012) Dennis Lindau et al.   IMMUNOLOGY

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

(2012) Joannes FM Jacobs et al.   LANCET ONCOLOGY

Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia

(2011) Thomas Schmidt et al.   CANCER CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

CD40/CD40L interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration

(2010) Daniel Urban et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

AdCD40L Immunogene Therapy for Bladder Carcinoma--The First Phase I/IIa Trial

(2010) P.-U. Malmstrom et al.   CLINICAL CANCER RESEARCH

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH